Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors by Hines DM, Rane P, Patel J, Harrison DJ, Wade RL

Get full text

Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment by Hines DM, Ding Y, Wade RL, Beaubrun A, Cohen JP

Get full text

Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterole... by Chen CC, Rane PB, Hines DM, Patel J, Harrison DJ, Wade RL

Get full text

Clinical and economic outcomes of a "high-touch" clinical management program for intravenous immunoglobulin therapy by Zhu J, Kirkham HS, Ayer G, Chen CC, Wade RL, Karkare SU, Robson CH, Orange JS

Get full text

Demographic And Clinical Characteristics Of Patients Prescribed Proprotein Convertase Subtilisin/kexin Type 9 Inhibitor Therapy And Patients Whose Current Lipid-Lowering Therapy Wa... by Baum SJ, Wade RL, Xiang P, Arellano J, Cerezo Olmos C, Nunna S, Chen CC, Carter CM, Desai NR

Get full text

Lipid-Lowering Therapy Utilization and Dosage Among Patients with Acute Coronary Syndrome Events: A Retrospective Cohort from 12 Community Hospitals by Khatib R, Yeh EJ, Glowacki N, McGuiness CB, Xie H, Wade RL, Kalich BA, Li Y, Rifai A, Sawlani N

Get full text